3D1015 Injection for Patients With mCRPC
NCT07537010
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Castration-resistant Prostate Cancer, mCRPC
Interventions
DRUG:
Lu 177-PSMA-3D1015 Injection
Sponsor
Chunjing Yu